Cargando…
Management of Diabetes Associated with Nephrotic Syndrome: Therapeutic Potential of Dapagliflozin for Protracted Volume Retention
A 48-year-old female was admitted to our hospital presenting with a chief complaint of progressive swelling because of diabetic nephrotic syndrome. Dapagliflozin seemed to play a role in accelerating the patient’s urinary sodium excretion as well as reducing gross fluid retention despite the fact th...
Autores principales: | Imai, Toshimi, Akimoto, Tetsu, Ito, Chiharu, Masuda, Takahiro, Nagata, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644139/ https://www.ncbi.nlm.nih.gov/pubmed/26609216 http://dx.doi.org/10.4137/DTI.S31710 |
Ejemplares similares
-
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease
por: Ohara, Ken, et al.
Publicado: (2020) -
Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome
por: Okada, Mari, et al.
Publicado: (2017) -
Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury
por: Akimoto, Tetsu, et al.
Publicado: (2016) -
Minimal Change Nephrotic Syndrome Sequentially Complicated by Acute Kidney Injury and Painful Skin Ulcers due to Calciphylaxis
por: Sato, Ryuta, et al.
Publicado: (2016) -
Therapeutic Challenges to End-Stage Kidney Disease in a Patient with Tetralogy of Fallot
por: Ohara, Ken, et al.
Publicado: (2015)